Cozzi Gabriele, Musi Gennaro, Ferro Matteo, Prestianni Pierpaolo, Bianchi Roberto, Giulia Garelli, Alessandro Mistretta Francesco, Luzzago Stefano, Pennacchioli Elisabetta, de Cobelli Ottavio
Division of Urology, European Institute of Oncology, IRCCS Via Ripamonti, 435, 20141 Milan, Italy.
Division of Urology, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.
Ther Adv Urol. 2020 Apr 1;12:1756287220913386. doi: 10.1177/1756287220913386. eCollection 2020 Jan-Dec.
Inguinal lymphadenectomy remains the gold standard for the treatment of inguinal lymph node metastases from penile carcinoma, melanoma, Merkel cell carcinoma, and squamous cell carcinoma (SCC). This procedure is associated with significant complications. In order to reduce morbidity, minimally invasive approaches have been described. We report our preliminary experience with robot-assisted inguinal lymphadenectomies (RAIL).
RAIL was performed according to the Sotelo technique. When indicated, a robot-assisted pelvic lymphadenectomy (RAPLND) was performed. We recorded age, sex, comorbidities, baseline oncologic diagnosis, operative time, hospital stay, lymph node yield, complications, time to drain removal, and oncologic outcomes.
From December 2016 to February 2019, 13 patients underwent RAIL. Median age was 65 years (range: 31-85 years). Primary malignancy was melanoma in five patients, Merkel cell carcinoma in four, dermal duct tumor in one, penile cancer in two, and SCC in one. RAIL was monolateral in 12 cases and bilateral in 1 case. A total of 10 monolateral RAPLNDs were performed; median operative time was 279 min (range: 169-320). Median lymph nodes yield was 11 (range: 2-24) for monolateral RAIL and 9 for monolateral RAPLND (range 2-24). Median hospital stay was 4 days (range: 2-5). No procedure was converted to open. Median follow up was 16 months (range: 5-31). Five Clavien-Dindo grade I complications were recorded. Median time to drain removal was 32.5 days (range 7-65). Three recurrences and two cancer-related deaths were recorded.
RAIL is feasible and associated with a short hospital stay, with little incidence of perioperative complications.
腹股沟淋巴结清扫术仍然是治疗阴茎癌、黑色素瘤、默克尔细胞癌和鳞状细胞癌(SCC)腹股沟淋巴结转移的金标准。该手术会引发严重并发症。为了降低发病率,人们已经描述了微创方法。我们报告了我们在机器人辅助腹股沟淋巴结清扫术(RAIL)方面的初步经验。
RAIL根据索特洛技术进行。如有指征,则进行机器人辅助盆腔淋巴结清扫术(RAPLND)。我们记录了年龄、性别、合并症、基线肿瘤诊断、手术时间、住院时间、淋巴结收获量、并发症、引流管拔除时间和肿瘤学结果。
2016年12月至2019年2月,13例患者接受了RAIL。中位年龄为65岁(范围:31 - 85岁)。原发性恶性肿瘤中,5例为黑色素瘤,4例为默克尔细胞癌,1例为皮肤导管肿瘤,2例为阴茎癌,1例为SCC。RAIL单侧手术12例,双侧手术1例。共进行了10例单侧RAPLND;中位手术时间为279分钟(范围:169 - 320)。单侧RAIL的中位淋巴结收获量为11个(范围:2 - 24),单侧RAPLND为9个(范围2 - 24)。中位住院时间为4天(范围:2 - 5)。无手术转为开放手术。中位随访时间为16个月(范围:5 - 31)。记录到5例Clavien-Dindo I级并发症。中位引流管拔除时间为32.5天(范围7 - 65)。记录到3例复发和2例癌症相关死亡。
RAIL是可行的,住院时间短,围手术期并发症发生率低。